BrainStorm Therapeutics, Inc.
BrainStorm Therapeutics is transforming CNS drug discovery through a proprietary platform that integrates patient-derived brain organoids with advanced computational tools. Their NSF-funded and NVIDIA-award-winning approach focuses on developing disease-modifying therapies for complex neurological disorders, leveraging biomarker-based screening and machine learning to enhance clinical translation. The company aims to address significant unmet needs in treating rare genetic neurodevelopmental disorders and other brain diseases, with a mission to accelerate the discovery of effective treatments while reducing costs and risks associated with drug development.
BrainStorm Therapeutics, Inc.
BrainStorm Therapeutics is transforming CNS drug discovery through a proprietary platform that integrates patient-derived brain organoids with advanced computational tools. Their NSF-funded and NVIDIA-award-winning approach focuses on developing disease-modifying therapies for complex neurological disorders, leveraging biomarker-based screening and machine learning to enhance clinical translation. The company aims to address significant unmet needs in treating rare genetic neurodevelopmental disorders and other brain diseases, with a mission to accelerate the discovery of effective treatments while reducing costs and risks associated with drug development.